Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine in Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT07581405Phase 2Not yet recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in gastric cancer (GC), sponsored by University of Illinois Chicago. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
olanzapine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07581405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581405.